Missed the Congress ? NO Problem

Register to Watch Talks Replays
Immunotherapeutics 2023 | EUSTM Virtual Congress

Dr Antonella Bresin Bresin

Istituto Dermopatico dell’Immacolata, Rome, Italy

About this speaker

Antonella Bresin currently works at the molecular oncology, Istituto Dermopatico dell'Immacolata. Antonella does research in Molecular Biology, Cell Biology, Animal Models and Cancer Research. The most recent publication is 'Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a New Therapeutic Strategy against Cutaneous T Cell Lymphoma'

Solid Tumors Diagnostics & Biomarkers Liver Cancer Melanoma

Talks

Scientific Session C: Solid Tumors Immunotherapeutics

07 May 2023, 10:00 AM
Dr Antonella Bresin Bresin Prof. Zuo-Feng Zhang

Junshi Biosciences

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics.

Hemosure

We at Hemosure are proud to manufacture and sell the fastest-growing Immunological Fecal Immunochemical Test (FIT) and have established its place as an industry leader.

Incyte

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Want to sponsor this event? Contact Us

Ready to learn from the best?

Book your place now

Book my place